Ispaghula sensitization in workers manufacturing a bulk laxative
- 1 March 1990
- journal article
- research article
- Published by Wiley in Clinical and Experimental Allergy
- Vol. 20 (2) , 199-202
- https://doi.org/10.1111/j.1365-2222.1990.tb02668.x
Abstract
Summary: Exposure to ispaghula dust in a pharmaceutical factory resulted in chest tightness/ wheeze, nasal, and ocular or skin symptoms in 48 of 92 exposed workers. Whilst symptoms were not incapacitating in the majority (44) of these, one worker required antihistamines and three others experienced severe respiratory symptoms when exposed to the dust. These three were atopic, had a positive RAST and skin test to ispaghula; a combination unique to them. There was a significant relationship between work‐related symptoms and atopic status, however, smoking did not influence symptoms, total serum IgE and specific anti‐ispaghula IgE. We conclude that handling ispaghula produces an irritant effect in most exposed people, however, sensitization to the dust can occur with severe respiratory symptoms.This publication has 16 references indexed in Scilit:
- Allergy to inhaled egg materialClinical and Experimental Allergy, 1983
- Another smoking hazard: raised serum IgE concentration and increased risk of occupational allergy.BMJ, 1981
- Ispagula powder – an allergen in the work environmentScandinavian Journal of Work, Environment & Health, 1979
- Asthma from Psyllium in Laxative ManufactureAnnals of Internal Medicine, 1975
- Clinical significance of measurement of reaginic (IgE) antibody by RastClinical and Experimental Allergy, 1973
- AN OUTBREAK OF RESPIRATORY SYMPTOMS CAUSED BY TOLUENE DI-ISOCYANATEThe Lancet, 1963